Standout Papers

Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial... 2019 2026 2021 2023 328
  1. Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease (2019)
    Hiddo J.L. Heerspink, Paul Perco et al. Diabetologia

Immediate Impact

2 by Nobel laureates 17 from Science/Nature 68 standout
Sub-graph 1 of 23

Citing Papers

Frailty in Older Adults
2024 Standout
SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys
2024 StandoutScience
3 intermediate papers

Works of Paul Perco being referenced

Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease
2009
Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation
2008

Author Peers

Author Last Decade Papers Cites
Paul Perco 1076 556 574 105 2.9k
Byron P. Croker 1272 750 555 100 5.2k
Yeong Jin Choi 680 437 758 141 2.8k
R. C. Atkins 942 1696 575 86 5.0k
Ju-Young Moon 702 772 335 97 2.0k
Holger Schmid 1072 1271 301 63 3.3k
John P. Dowling 1196 1171 344 126 4.4k
Thomas J. Dengler 1663 369 808 109 4.2k
Ashwani Khanna 804 275 759 147 3.1k
Marie Essig 470 551 701 115 2.7k
Stéphane Decramer 1250 907 600 100 3.2k

All Works

Loading papers...

Rankless by CCL
2026